These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8539920

  • 21. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody.
    Osorio RW, Ascher NL, Melzer JS, Stock PG.
    Transplant Proc; 1994 Apr; 26(2):749. PubMed ID: 8171642
    [No Abstract] [Full Text] [Related]

  • 22. Anti-ICAM-1/LFA-1 monoclonal antibody therapy prevents graft rejection and IDDM recurrence in BB rat pancreas transplantation.
    Uchikoshi F, Ito T, Kamiike W, Moriguchi A, Nozaki S, Ito A, Kuhara A, Miyata M, Matsuda H, Miyasaka M.
    Transplant Proc; 1995 Apr; 27(2):1527-8. PubMed ID: 7725399
    [No Abstract] [Full Text] [Related]

  • 23. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
    Nishihara M, Gotoh M, Ohzato H, Ohta Y, Luo Z, Dono K, Umeshita K, Sakon M, Monden M, Yagita H, Okumura K, Miyasaka M.
    Transplantation; 1997 Oct 15; 64(7):965-70. PubMed ID: 9381542
    [Abstract] [Full Text] [Related]

  • 24. Treatment with antibodies to leucocyte function-associated antigen-1 prolongs the survival of xenotransplanted islets of Langerhans.
    Bühler L, Deng S, Grau G, Mentha G, Rohner A, Morel P.
    Transplant Proc; 1994 Jun 15; 26(3):1360-1. PubMed ID: 8029940
    [No Abstract] [Full Text] [Related]

  • 25. Blocking of ICAM-1 and LFA-1 in rat liver transplantation.
    Degawa H, Watanabe K, Uchida H, Nagao T, Tomikawa S, Beck Y, Nomura Y, Ichikawa N, Ando Y, Kikuchi K, Ito S.
    Transplant Proc; 1996 Jun 15; 28(3):1362-3. PubMed ID: 8658695
    [No Abstract] [Full Text] [Related]

  • 26. ICAM-1 expressed on hepatic stellate cells plays an important role in immune regulation.
    Yin Z, Jiang G, Fung JJ, Lu L, Qian S.
    Microsurgery; 2007 Jun 15; 27(4):328-32. PubMed ID: 17477408
    [Abstract] [Full Text] [Related]

  • 27. Prolongation of islet allograft survival following immunologic conditioning by antigen-feeding in the pig.
    Hrstka J, Hesse UJ, Hrstka V, Danis J, Schmitz-Rode M, Tunggal B, Hördegen P, Peters S.
    Transplant Proc; 1992 Apr 15; 24(2):663-4. PubMed ID: 1566472
    [No Abstract] [Full Text] [Related]

  • 28. Permanent acceptance of mitomycin C-treated islet allograft.
    Matsuyama S, Gunji T, Ise K, Sato Y, Saito T, Gotoh M.
    Transplantation; 2003 Jul 15; 76(1):65-71. PubMed ID: 12865788
    [Abstract] [Full Text] [Related]

  • 29. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M, Jendrisak G, Gamero J, Mohanakumar T.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract] [Full Text] [Related]

  • 30. Role of ICAM-1 and LFA-1 in a cardiac xenograft rejection model.
    Miwa S, Kawasaki S, Makuuchi M, Miyasaka M, Yamazaki S, Sekiguchi M, Isobe M.
    Transplant Proc; 1995 Feb 15; 27(1):111-2. PubMed ID: 7878820
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of anti-intercellular adhesion molecule-1 immunotherapy on immune responses to allogeneic hepatocytes in mice.
    Bumgardner GL, Li J, Heininger M, Orosz CG.
    Hepatology; 1998 Oct 15; 28(4):1005-12. PubMed ID: 9755237
    [Abstract] [Full Text] [Related]

  • 32. Dose dependent immunosuppressive effects of antibodies to ICAM-1 and LFA-1 on hepatic allografts.
    Harihara Y, Sugawara Y, Inoue K, Kubota K, Bandai Y, Makuuchi M, Miyasaka M.
    Transplant Proc; 1996 Jun 15; 28(3):1794-5. PubMed ID: 8658886
    [No Abstract] [Full Text] [Related]

  • 33. Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody.
    Zeng Y, Torres MA, Thistlethwaite JR, Montag A, Bluestone JA.
    Transplant Proc; 1994 Jun 15; 26(3):1120. PubMed ID: 7913254
    [No Abstract] [Full Text] [Related]

  • 34. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
    Desai NM, Bassiri H, Odorico JS, Koller BH, Smithies O, Naji A, Barker CF, Markmann JF.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 2):961-2. PubMed ID: 8442280
    [No Abstract] [Full Text] [Related]

  • 35. Prevention of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice by treatment with antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1.
    Hayashi T, Yamamoto S, Onodera T.
    Int J Exp Pathol; 1995 Dec 15; 76(6):403-9. PubMed ID: 8652360
    [Abstract] [Full Text] [Related]

  • 36. Consistent long-term allograft survival in murine pancreatic islet transplants without immunosuppression.
    Jain K, Cai BR, Patel S, Yang H, Smith BH, Suthanthiran M, Rubin AL.
    Transplant Proc; 1994 Dec 15; 26(6):3492-3. PubMed ID: 7998243
    [No Abstract] [Full Text] [Related]

  • 37. Fifty islets maintain euglycemia and survive longer than 200 islets in allogeneic and xenogeneic diabetic hosts.
    Ohzato H, Porter J, Monaco AP, Maki T.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 2):953-4. PubMed ID: 8442277
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M.
    J Immunol; 1996 Oct 15; 157(8):3737-43. PubMed ID: 8871677
    [Abstract] [Full Text] [Related]

  • 40. Prolongation of hepatic allograft survival with antibodies to ICAM-1 and LFA-1.
    Harihara Y, Sakamoto H, Sanjo K, Otsubo O, Watanabe G, Idezuki Y.
    Transplant Proc; 1994 Aug 15; 26(4):2258. PubMed ID: 7915063
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.